Hospital Pharmacy - October 2017 - 615

Hammond et al
3. American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 5th ed. Washington, DC:
American Psychiatric Publishing; 2013.
4. Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol
withdrawal syndrome. Am Fam Physician. 2004;69(60):
1443-1450.
5. Trevisan LA, Boutros N, Petrakis IL, Krystal JH. Complications
of alcohol withdrawal: pathophysiological insights. Alcohol
Health Res World.1998;22(1):61-66.
6. Kattimani S, Bharadwaj B. Clinical management of alcohol withdrawal: a systematic review. Ind Psychiatry J.
2013;22(2):100-108.
7. Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010;38:S494-S501.
8. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of
human alcoholism. Am J Psychiatry. 1995;152(3):332-340.
9. Hoffman PL, Grant KA, Snell LD, Reinlib L, Iorio K, Tabakoff
B. NMDA receptors: role in ethanol withdrawal seizures. Ann
N Y Acad Sci. 1992;654:52-60.
10. O'Brien JM Jr, Lu B, Ali NA, et al. Alcohol dependence is
independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care
Med. 2007;35(2):345-350.
11. Awissi D, Lebrun G, Coursin DB, Riker RR, Skrobik Y.
Alcohol withdrawal and delirium tremens in the critically ill:
a systematic review and commentary. Intensive Care Med.
2013;39(1):16-30.
12. Genther D, Gourin C. The effect of alcohol abuse and alcohol withdrawal on short-term outcomes and cost of care after
head and neck cancer surgery. Laryngoscope. 2012;122(8):
1739-1747.
13. Brotherton AL, Hamilton EP, Kloss HG, Hammond DA.
Propofol for treatment of refractory alcohol withdrawal
syndrome: a review of the literature. Pharmacotherapy.
2016;36(4):433-442.
14. Wong A, Smithburger PL, Kane-Gill SL. Review of adjunctive dexmedetomidine in the management of severe acute
alcohol withdrawal syndrome. Am J Drug Alcohol Abuse.
2015;41(5):382-391.
15. Wong A, Benedict NJ, Kane-Gill SL. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. J Crit Care.
2015;30(2):405-409.
16. Crispo AL, Daley MJ, Pepin JL, Harford PH, Brown CV.
Comparison of clinical outcomes in nonintubated patients with
severe alcohol withdrawal syndrome treated with continuousinfusion sedatives: dexmedetomidine versus benzodiazepines.
Pharmacotherapy. 2014;34(9):910-917.
17. Rosenson J, Clements C, Simon B, et al. Phenobarbital for
acute alcohol withdrawal: a prospective randomized doubleblind placebo-controlled study. J Emerg Med. 2013;44(3):
592-598.
18. Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS.
Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute
Care Surg. 2014;77(6):938-943.
19. Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium
tremens. Crit Care Med. 2007;35(3):724-730.

615
20. Gashlin LZ, Groth CM, Wiegand TJ, Ashley ED. Comparison
of alcohol withdrawal outcomes in patients treated with benzodiazepines alone versus adjunctive phenobarbital: a retrospective cohort study. Asia Pac J Med Toxicol. 2015;4:31-36.
21. Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P.
A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med.
2011;29(4):382-385.
22. Young GP, Rores C, Murphy C, Dailey RH. Intravenous phenobarbital for alcohol withdrawal and convulsions. Ann Emerg
Med. 1987;16(8):847-850.
23. Hjermø I, Anderson JE, Fink-Jensen A, Allerup P, Ulrichsen J.
Phenobarbital versus diazepam for delirium tremens-a retrospective study. Dan Med Bull. 2010;57(8):1-5.
24. Rosenthal RN, Perkkel C, Singh P, et al. A pilot open randomized trial of valproate and phenobarbital in the treatment of
acute alcohol withdrawal. Am J Addict. 1998;7:189-197.
25. Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict.
2006;15:76-84.
26. Tangmose K, Nielsen M, Allerup P, Ulrichsen J. Linear correlation between phenobarbital dose and concentration in alcohol
withdrawal patients. Dan Med Bull. 2010;57(8):1-4.
27. Kramp P, Rafaelsen OJ. Delirium tremens: a double-blind
comparison of diazepam and barbital treatment. Acta Psychiatr
Scand. 1978;58(2):174-190.
28. Flygenring J, Hansen J, Holst B, Petersen E, Sørensen A.
Treatment of alcohol withdrawal symptoms in hospitalized
patients. Acta Psychiatr Scand.1984;69(5):398-408.
29. Askgaard G, Hallas J, Fink-Jensen A, Molander AC, Madsen
KG, Pottegård A. Phenobarbital compared to benzodiazepines
in alcohol withdrawal treatment: a register-based cohort study
of subsequent benzodiazepine use, alcohol recidivism and mortality. Drug Alcohol Depend. 2016;161:258-264.
30. Hayner C, Wuestefeld N, Bolton P. Phenobarbital treatment in
a patient with resistant alcohol syndrome. Pharmacotherapy.
2009;29(7):875-878.
31. Ives TJ, Mooney AJ III, Gwyther RE. Pharmacokinetic dosing
of phenobarbital in the treatment of alcohol withdrawal syndrome. South Med J. 1991;84(1):18-21.
32. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers
EM. Assessment of alcohol withdrawal: the revised clinical
institute withdrawal assessment for alcohol scale (CIWA-Ar).
Br J Addict. 1989;84:1353-1357.
33. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered
vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med.
2002;162(10):1117-1121.
34. Spies CD, Otter HE, Huske B, et al. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy
in the ICU. Intensive Care Med. 2003;29:2230-2238.
35. Cassidy EM, O'Sullivan I, Bradshaw P, Islam T, Onovo C.
Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison
with the standard fixed dose benzodiazepine regimen. Emerg
Med J. 2012;29(10):802-804.
36. Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006;2(2):55-60.



Table of Contents for the Digital Edition of Hospital Pharmacy - October 2017

Pharmacists and Medical Missions
Current FDA-Related Drug Information
Summaries of Safety Labeling Changes Approved By FDA- Boxed Warnings Highlights April-June 2017
Pharmaceutical Pipeline Update
Cholesterol Ester Transfer Protein Inhibitor Review
Formulary Drug Review
Ocrelizumab
Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review
Development of a Pharmacy Technician–Driven Program to Improve Vaccination Rates at an Academic Medical Center
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Hemodialysis Patients
Multilayer Model of Pharmacy Participation in the Antimicrobial Stewardship Program at a Large Academic Medical Center
Impact of Inpatient Automatic Therapeutic Substitutions on Postdischarge Medication Prescribing
Impact of Respiratory Viral Panel Polymerase Chain Reaction Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients With Respiratory Viral Illnesses
Administration of Injectable Vitamin K Orally
Hospital Pharmacy - October 2017 - 577
Hospital Pharmacy - October 2017 - 578
Hospital Pharmacy - October 2017 - 579
Hospital Pharmacy - October 2017 - 580
Hospital Pharmacy - October 2017 - 581
Hospital Pharmacy - October 2017 - 582
Hospital Pharmacy - October 2017 - 583
Hospital Pharmacy - October 2017 - 584
Hospital Pharmacy - October 2017 - 585
Hospital Pharmacy - October 2017 - 586
Hospital Pharmacy - October 2017 - 587
Hospital Pharmacy - October 2017 - 588
Hospital Pharmacy - October 2017 - Pharmacists and Medical Missions
Hospital Pharmacy - October 2017 - Current FDA-Related Drug Information
Hospital Pharmacy - October 2017 - Summaries of Safety Labeling Changes Approved By FDA- Boxed Warnings Highlights April-June 2017
Hospital Pharmacy - October 2017 - 592
Hospital Pharmacy - October 2017 - Pharmaceutical Pipeline Update
Hospital Pharmacy - October 2017 - Cholesterol Ester Transfer Protein Inhibitor Review
Hospital Pharmacy - October 2017 - 595
Hospital Pharmacy - October 2017 - Formulary Drug Review
Hospital Pharmacy - October 2017 - Ocrelizumab
Hospital Pharmacy - October 2017 - 598
Hospital Pharmacy - October 2017 - 599
Hospital Pharmacy - October 2017 - 600
Hospital Pharmacy - October 2017 - 601
Hospital Pharmacy - October 2017 - 602
Hospital Pharmacy - October 2017 - 603
Hospital Pharmacy - October 2017 - 604
Hospital Pharmacy - October 2017 - Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review
Hospital Pharmacy - October 2017 - 606
Hospital Pharmacy - October 2017 - 607
Hospital Pharmacy - October 2017 - 608
Hospital Pharmacy - October 2017 - 609
Hospital Pharmacy - October 2017 - 610
Hospital Pharmacy - October 2017 - 611
Hospital Pharmacy - October 2017 - 612
Hospital Pharmacy - October 2017 - 613
Hospital Pharmacy - October 2017 - 614
Hospital Pharmacy - October 2017 - Development of a Pharmacy Technician–Driven Program to Improve Vaccination Rates at an Academic Medical Center
Hospital Pharmacy - October 2017 - 616
Hospital Pharmacy - October 2017 - 617
Hospital Pharmacy - October 2017 - 618
Hospital Pharmacy - October 2017 - 619
Hospital Pharmacy - October 2017 - 620
Hospital Pharmacy - October 2017 - Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Hemodialysis Patients
Hospital Pharmacy - October 2017 - 622
Hospital Pharmacy - October 2017 - 623
Hospital Pharmacy - October 2017 - 624
Hospital Pharmacy - October 2017 - 625
Hospital Pharmacy - October 2017 - Multilayer Model of Pharmacy Participation in the Antimicrobial Stewardship Program at a Large Academic Medical Center
Hospital Pharmacy - October 2017 - 627
Hospital Pharmacy - October 2017 - 628
Hospital Pharmacy - October 2017 - 629
Hospital Pharmacy - October 2017 - 630
Hospital Pharmacy - October 2017 - 631
Hospital Pharmacy - October 2017 - 632
Hospital Pharmacy - October 2017 - Impact of Inpatient Automatic Therapeutic Substitutions on Postdischarge Medication Prescribing
Hospital Pharmacy - October 2017 - 634
Hospital Pharmacy - October 2017 - 635
Hospital Pharmacy - October 2017 - 636
Hospital Pharmacy - October 2017 - 637
Hospital Pharmacy - October 2017 - Impact of Respiratory Viral Panel Polymerase Chain Reaction Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients With Respiratory Viral Illnesses
Hospital Pharmacy - October 2017 - 639
Hospital Pharmacy - October 2017 - 640
Hospital Pharmacy - October 2017 - 641
Hospital Pharmacy - October 2017 - 642
Hospital Pharmacy - October 2017 - Administration of Injectable Vitamin K Orally
Hospital Pharmacy - October 2017 - 644
Hospital Pharmacy - October 2017 - 645
Hospital Pharmacy - October 2017 - 646
Hospital Pharmacy - October 2017 - 647
Hospital Pharmacy - October 2017 - 648
Hospital Pharmacy - October 2017 - 649
Hospital Pharmacy - October 2017 - 650
Hospital Pharmacy - October 2017 - 651
Hospital Pharmacy - October 2017 - 652
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com